BackArcus Biosciences Overview

Arcus Biosciences Cost of Revenue

Cost of Revenue analysis for RCUS.

Quarterly Cost of Revenue

$2.00M

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$7.00M

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)